Quantcast

Latest Varenicline Stories

2014-06-17 12:39:17

Duke University Medical Center Combining two smoking cessation therapies is more effective than using just one for male and highly nicotine-dependent smokers who weren't initially helped by the nicotine patch, according to researchers at Duke Medicine. The findings, published online June 17, 2014, in the American Journal of Psychiatry, also support using an adaptive treatment model to determine which smokers are likely to succeed in quitting with nicotine replacement alone before...

2014-05-16 23:04:42

Transparency Market Research published a new report "Smoking Cessation and Nicotine De-addiction Products Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse full report: http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html. Albany, New York (PRWEB) May 16, 2014 Smoking Cessation and Nicotine De-addiction Products Market was valued at USD 5.1 billion in 2012 and is expected...

2014-04-17 08:24:57

ALBANY, New York, April 17, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Smoking Cessation and Nicotine De-Addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-Cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its large collection of research report. Smoking cessation or nicotine de-addiction can be achieved by various modes such...

2014-04-07 23:25:20

ResearchMoz.us include new market research report "OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update" to its huge collection of research reports.Browse All GlobalData Reports @http://www.researchmoz.us/publisher/globaldata-1.html Albany,New York (PRWEB) April 07, 2014 Researchmoz presents this most up-to-date research on"OpportunityAnalyzer Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and...

2014-04-04 12:27:51

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6ctxcw/smoking_cessation ) has announced the addition of the "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Smoking cessation products are a better alternative for tobacco and cigarette addicts. Smoking cessation...

2014-03-25 12:26:40

ALBANY, New York, March 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global smoking cessation and nicotine de-addiction productsmarket was valued at USD 5.1 billion in...

2014-01-08 17:16:13

Among cigarette smokers, combining the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in higher smoking abstinence rates for one outcome but not the other at three and six months; rates were similar at one year, according to a Mayo Clinic study published this month in JAMA. "We were interested in seeing if combining different medications together can improve the ability of patients to quit over and above single drug therapy," says lead...

2014-01-08 11:47:21

Among cigarette smokers, the combined use of the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in better rates of smoking abstinence at 12 weeks, but rates were similar after one year, according to a study in the January 8 issue of JAMA. Smoking accounts for 62 percent of deaths among female smokers and 60 percent of deaths among male smokers. Innovative pharmacotherapeutic approaches to tobacco-dependence treatment need investigation to...

2014-01-08 11:41:42

Extended treatment with the smoking cessation drug varenicline (Chantix) significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment. In this Massachusetts General Hospital (MGH) study – the first randomized, controlled trial of maintenance pharmacotherapy for smoking cessation in such patients – participants who quit smoking and then received varenicline along with cognitive behavioral...

2013-12-10 10:12:48

Three major types of smoking cessation therapies don't increase the risk of heart attack, stroke or heart-related death, according to research published in the American Heart Association journal Circulation. In recent years, there has been concern that some smoking cessation products may have serious cardiovascular risks. But in the largest analysis of side effects (63 clinical trials and 30,508 people), serious heart events didn't increase with nicotine replacement gums and patches or the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related